A carbon quantum dot composite material with nuclide decontamination and real-time monitoring of decontamination effect, and a preparation method and application thereof
By preparing carbon quantum dot composite materials (C-CDs), the problem of lagging radionuclide decontamination and monitoring has been solved, realizing efficient and real-time radionuclide decontamination and monitoring, which is suitable for nuclear emergency surface contamination treatment.
Patent Information
- Application Number
- CN202611281582.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-08-21
- Publication Date
- 2026-11-17
AI Technical Summary
Existing decontamination technologies cannot effectively remove radionuclide contamination and monitor the decontamination effect in real time, resulting in blind decontamination operations, and traditional detection methods are lagging behind and cannot provide dynamic feedback.
A carbon quantum dot composite material (C-CDs) was developed, consisting of carboxymethyl chitosan, carbon quantum dots (CQDs), and a crosslinking agent. It was prepared by stirring, filtering, and freeze-drying to achieve efficient radionuclide decontamination and real-time fluorescence monitoring.
It achieves efficient and broad-spectrum decontamination of strontium, cesium, and thorium, dynamically correlates fluorescence signals with the degree of radionuclide residue, provides real-time monitoring endpoint determination, has good biocompatibility, and is rapid and safe.
Smart Images

Figure CN123107670A_ABST
Abstract
Description
Technical Field
[0001] This invention relates to the field of decontamination product technology, and in particular to a carbon quantum dot composite material that combines radionuclide decontamination with real-time monitoring of the decontamination effect, its preparation method, and its application. Background Technology
[0002] In scenarios such as nuclear accidents, nuclear medicine applications, and the operation and maintenance of nuclear facilities, personnel may be contaminated with radioactive nuclides (such as strontium-90, cesium-137, thorium, etc.). Existing decontamination technologies face two major bottlenecks: (1) High permeability of nuclides and limited decontamination efficiency: Some nuclides (such as cesium and strontium) have small ionic radii and fast migration speed, which can easily pass through the skin barrier and enter the body, causing continuous internal irradiation damage. Traditional decontamination agents (such as EDTA and DTPA) have problems such as insufficient broad spectrum and incomplete decontamination.
[0003] (2) Lagging monitoring methods for the decontamination process: The current assessment of the decontamination effect mainly relies on handheld nuclide detectors (such as Geiger counters) or inductively coupled plasma mass spectrometry (ICP-MS) analysis after offline sampling. It is impossible to provide real-time and dynamic feedback on the residual nuclide level during the decontamination process, resulting in blindness in the decontamination operation (over-decontamination or under-decontamination).
[0004] Therefore, there is an urgent need to develop a new composite material that combines efficient broad-spectrum decontamination with real-time fluorescence monitoring to achieve synergistic optimization of nuclear contamination removal and process monitoring. Summary of the Invention
[0005] To address the aforementioned shortcomings, the present invention aims to provide a novel carbon quantum dot composite material (C-CDs) that integrates efficient decontamination, real-time monitoring, and good biocompatibility. This solves the core problems of traditional decontamination agents, such as limited functionality and delayed monitoring, and provides a novel intelligent solution for nuclear emergency surface contamination treatment. Specifically, it relates to a carbon quantum dot composite material that combines radionuclide decontamination with real-time monitoring of the decontamination effect, its preparation method, and its applications.
[0006] To achieve the above-mentioned objectives, the present invention provides the following technical solution: This invention provides a carbon quantum dot composite material comprising the following components: Carboxymethyl chitosan, carbon quantum dots (CQDs), and crosslinking agents; The mass ratio of carbon quantum dots (CQDs) to carboxymethyl chitosan is 5-25:1. The crosslinking agent is N-hydroxysuccinimide and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide; The mass ratio of N-hydroxysuccinimide to 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide is 1~3:1; The mass ratio of carboxymethyl chitosan to crosslinking agent is 0.5~7:1.
[0007] This invention also provides a method for preparing carbon quantum dot composite materials, comprising the following steps: (1) Mix carboxymethyl chitosan, carbon quantum dots (CQDs) and crosslinking agent with water and stir for 10-14 hours to obtain a mixture; (2) Filter the mixture, take the filtrate, dialyze for 45-51 hours, and dry to obtain carbon quantum dot composite material.
[0008] Preferably, the stirring speed is 150~250 rpm.
[0009] Preferably, the drying is freeze drying; the freeze drying temperature is -45℃ to -55℃; and the freeze drying time is 70 to 74 hours.
[0010] The present invention also provides the application of the carbon quantum dot composite material or the carbon quantum dot composite material prepared according to the preparation method described above in radionuclide decontamination and monitoring of decontamination effect.
[0011] Preferably, the nuclide is one or more of strontium, cesium, and thorium.
[0012] Preferably, the scenarios for radionuclide decontamination of the carbon quantum dot composite material include radionuclide-contaminated wound decontamination, radionuclide-contaminated human skin surface decontamination, or radionuclide-contaminated object surface decontamination.
[0013] The present invention also provides the application of the carbon quantum dot composite material or the carbon quantum dot composite material prepared according to the preparation method described above in the preparation of products that combine radionuclide decontamination with real-time monitoring of decontamination effect.
[0014] The present invention has the following advantages: The carbon quantum dot composite material prepared by this invention has the following effects: (1) Achieved efficient and broad-spectrum radionuclide decontamination capability: In a guinea pig skin contamination model, carbon quantum dot composite materials (C-CDs) showed high efficiency in decontaminating strontium Sr². + Cesium Cs + Th 4+ The decontamination rate reached 95.98%, which was significantly higher than that of physiological saline (69.91%), pure carbon quantum dots (CQDs) (84.59%) and pure carboxymethyl chitosan (CMCS) (87.74%).
[0015] ICP-MS verification showed that the radionuclide content in the C-CDs washing solution was 1.86 times that of the physiological saline group, proving that it has a stronger radionuclide complexation and retention capacity.
[0016] (2) Real-time fluorescence dynamic monitoring of the disinfection process was realized for the first time: Using a graded disinfection strategy, it was found that as the number of washes increased, the fluorescence intensity of C-CDs recovered in a gradient manner. After the fifth disinfection, the fluorescence recovered to more than 96% of the initial value, which was highly consistent with the decreasing trend of nuclide content measured by ICP-MS.
[0017] It achieves a dynamic correlation between "fluorescence signal intensity" and "the degree of radionuclide residue on the skin surface", providing a new, visualized, and real-time method for determining the endpoint of decontamination.
[0018] (3) The fluorescence quenching mechanism was revealed, and the response was fast and reliable: the quenching mechanism was clarified as the synergistic effect of dynamic quenching and aggregation-induced quenching (ACQ). After the nuclide ions electrostatically bind to C-CDs, they induce the aggregation of composite materials (the particle size increases from ~13 nm to >150 nm), which activates the non-radiative transition channels.
[0019] C-CDs can undergo fluorescence quenching within 10 seconds of contact with the nuclide, with a rapid response and stable signal after quenching, meeting the needs of emergency rapid detection.
[0020] Th 4+ Due to its high charge density, it has the strongest quenching ability (lifetime reduced by 2.58 ns, quenching rate 0.97).
[0021] (4) Excellent biosafety was verified: Cytotoxicity: L929 cells were co-cultured with C-CDs for 72 h, and the cell viability was ≥80%, with no cytotoxicity.
[0022] Skin irritation: In the New Zealand rabbit skin patch test, the primary irritation index (PII) was 0 (very mild), which was no different from that of physiological saline and far superior to the SDS positive control (PII=5, severe irritation).
[0023] Acute toxicity: Mice were given a single intraperitoneal injection of 50 mg / kg. After 15 days, the survival rate was 100%, the weight gained normally, and there was no neurotoxicity or behavioral abnormality.
[0024] In summary, this invention provides a novel C-CDs composite material that integrates efficient decontamination, real-time monitoring, and good biocompatibility, solving the core problems of traditional decontamination agents having limited functionality and lagging monitoring, and providing a new intelligent solution for the treatment of nuclear emergency surface contamination. Attached Figure Description
[0025] Figure 1Fluorescence intensity of C-CDs composites synthesized with different mass ratios of CQDs and CMCS (A represents fluorescence intensity when CQDs and CMCS are 5:1 / 10:1; B represents fluorescence intensity when CQDs and CMCS are 20:1 / 25:1; C represents fluorescence intensity when CQDs and CMCS are 15:1). Figure 2 Morphological characteristics of CQDs and C-CDs (A is TEM image and particle size distribution map of CQDs; B is TEM image and particle size distribution map of C-CDs). Figure 3 X-ray diffraction patterns of CQDs, CMCSs, and C-CDs; Figure 4 Comparison of infrared spectra of CQDs, C-CDs, and CMCS; Figure 5 XPS total spectrum comparison for CQDs, C-CDs and CMCS; Figure 6 Comparison of C1s, N1s, and O1s resolved spectra of CQDs, C-CDs, and CMCS; Figure 7 Optical characterization of CQDs and C-CDs (A is the UV spectrum of CQDs and C-CDs; B is the fluorescence spectrum of CQDs and C-CDs). Figure 8 Emission spectra of C-CDs at different excitation wavelengths; Figure 9 For the C-CDs decontamination capability test (A is the strontium removal rate on the skin; B is the strontium content in the decontamination solution); Figure 10 For the C-CDs decontamination capability test (A is the cesium removal rate on the skin; B is the cesium content in the decontamination solution); Figure 11 For the C-CDs decontamination capability test (A is the thorium removal rate on the skin; B is the thorium content in the decontamination solution); Figure 12 Real-time monitoring capability of C-CDs was tested (A represents the change in fluorescence intensity of C-CDs during the disinfection process; B represents the strontium content in the disinfection solution during the disinfection process). Figure 13 Real-time monitoring capability of C-CDs was tested (A represents the change in fluorescence intensity of C-CDs during the disinfection process; B represents the cesium content in the disinfection solution during the disinfection process). Figure 14 Real-time monitoring capability of C-CDs was tested (A represents the change in fluorescence intensity of C-CDs during the decontamination process; B represents the thorium content in the decontamination solution during the decontamination process). Figure 15 For Sr 2+ Cs +,Th 4+ Effect of Sr on the fluorescence lifetime of C-CDs (A is Sr 2+ For the fluorescence lifetime of C-CDs, B is Cs + For the fluorescence lifetime of C-CDs, C is Th 4+ (for the fluorescence lifetime of C-CDs) Figure 16 Add Sr to C-CDs respectively 2+ Cs + ,Th 4+ The UV spectrum after adding Sr (A is the UV spectrum after adding Sr) 2+ The ultraviolet spectrum of B is the result of adding Cs. + The ultraviolet spectrum of C is the result of adding Th. 4+ (ultraviolet spectrum); Figure 17 Add Sr to C-CDs respectively 2+ Cs + ,Th 4+ The change in zeta potential after adding Sr (A is the value of Sr added) 2+ The change in ζ potential, B is the addition of Cs + The change in ζ potential, C is the addition of Th 4+ (the change in ζ potential); Figure 18 Add Sr to C-CDs respectively 2+ The subsequent particle size change; Figure 19 Add Cs to C-CDs respectively + The subsequent particle size change; Figure 20 Add Th to C-CDs respectively 4+ The subsequent particle size change; Figure 21 For CQDs, C-CDs and Sr 2+ Cs + ,Th 4+ Fluorescence spectra during coexistence; Figure 22 For the study of C-CD response time (A represents the fluorescence intensity of C-CDs at different time points after the addition of strontium; B represents the fluorescence quenching of C-CDs at different time points); Figure 23 For the study of C-CD response time (A represents the fluorescence intensity of C-CDs at different time points after the addition of cesium; B represents the fluorescence quenching of C-CDs at different time points); Figure 24 For the study of C-CD response time (A represents the fluorescence intensity of C-CDs at different time points after the addition of thorium; B represents the fluorescence quenching of C-CDs at different time points); Figure 25 is the skin action site; Figure 26 is the cell viability of each group (n=3); Figure 27 is the skin irritation diagram of New Zealand rabbits; Figure 28 is the body weight change diagram of the C-CDs, CQDs and C-CDs, CQDs and normal saline groups (n=10). Detailed Description of the Embodiments
[0026] The solutions provided by the present invention are described in detail below with reference to the embodiments, but they should not be construed as limiting the protection scope of the present invention.
[0027] The preparation method of carbon quantum dots (CQDs) in the embodiments of the present invention is as follows: using citric acid monohydrate as the carbon precursor and polyethyleneimine as the nitrogen dopant, the CQDs are prepared by a hydrothermal method. Weigh 1.0 g of citric acid monohydrate (CA) and 0.5 g of polyethyleneimine (BPEI), pour them into a beaker, add 25 mL of ultrapure water, fully dissolve them by ultrasonic stirring, then load the mixed solution into a 100 mL high-pressure reaction vessel equipped with a tetrafluoroethylene liner, set the temperature to 180°C for continuous heating for 10 hours, place the vessel in a fume hood to cool slowly to room temperature, and the obtained product is a tan transparent solution. Place the solution in a high-speed refrigerated centrifuge, set the rotor speed to 10000 rpm for centrifugal separation for 15 minutes, perform sterile filtration on the mixed solution with a 0.22 μm microporous membrane, load the filtrate into a pre-treated dialysis bag, replace the external dialysis solution every 6 to 8 hours on average, pre-freeze the liquid for 24 hours, then transfer it to a lyophilizer with a condensation temperature of -50°C for drying for 3 days, and finally obtain yellow spongy CQDs powder.
[0028] The main experimental instruments in the embodiments of the present invention are shown in Table 1: Table 1 Experimental Instruments
[0029] The main reagents in the embodiments of the present invention are shown in Table 2: Table 2 Main Drugs and Reagents
[0030] The experimental animals in Example 2 of the present invention are male guinea pigs (clean grade) with an initial body weight of 250~300 g. The experimental animals are sourced from Beijing Keyu Animal Breeding Center, and the production license number for experimental animals is SCXK (Beijing) 2021-0011. The environmental parameters are strictly controlled under standardized conditions with a temperature range of 22~26°C, a relative humidity of 50%~60%, and a 12-hour alternating light and dark cycle.
[0031] The mouse fibroblast epithelial cells (L929) in Example 3 of the present invention are quality-certified and supplied by the Cell Bank of the Chinese Academy of Sciences; experimental animals: male New Zealand white rabbits, clean grade, weighing 2.5 to 3 kg, sourced from Beijing Keyu Animal Breeding Center, with the experimental animal production license: SCXK (Jing) 2024-0008; Kunming (KM) male mice, SPF grade, weighing 18~20g, purchased from Beijing Vital River Laboratory Animal Technology Co., Ltd., with the experimental animal production license number: SYXK (Jing) 2021-0011. The animal experiment protocol (approval number: IACUC-DWZX-2020-503) has been reviewed and certified by the Laboratory Animal Use Ethics Committee of the Academy of Military Medical Sciences.
[0032] Example 1
[0033] Preparation of carbon quantum dot composite material (C-CDs)
[0034] 1. Preparation of C-CDs
[0035] Using N-hydroxysuccinimide (NHS) and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide (EDC) as crosslinking agents, CMCS (carboxymethyl chitosan) is covalently grafted onto the surface of CQDs (amino) to synthesize C-CDs. Briefly, CMCS is dissolved in deionized water and stirred until fully dissolved, then NHS and EDC are added to the solution in sequence, and stirring is continued at 4°C to complete the carboxyl activation reaction. CQDs are added to the reaction system, and stirring is continued at 200 rpm for 12 h. Unreacted starting materials are removed by filtration, the filtrate is dialyzed against deionized water for 48 h, and freeze-dried at -50°C for 72 h to obtain a brown solid, which is used as the final product of C-CDs.
[0036] 2. Optimization of C-CDs preparation process
[0037] To determine the optimal synthesis process, a screening experiment for grafting reaction conditions is first carried out: five mass ratios of CQDs to CMCS of 5:1, 10:1, 15:1, 20:1, and 25:1 are selected for parallel experiments, and the dosage of crosslinking agent NHS / EDC is optimized (190mg / 120mg or 23mg / 9mg), and the optimal synthesis conditions for the C-CDs functionalized decontaminant are comprehensively determined based on the water solubility and fluorescence intensity as criteria.
[0038] The following physicochemical characterizations are all experiments carried out on C-CDs prepared by the optimal process.
[0039] 3. Physicochemical characterization of C-CDs
[0040] 3.1 Transmission electron microscopy characterization (TEM)
[0041] The morphology and particle size of C-CDs were characterized using transmission electron microscopy (TEM) and high-resolution transmission electron microscopy (HR-TEM).
[0042] 3.2 X-ray diffraction characterization (XRD)
[0043] XRD was used to analyze the phase composition and crystal structure of C-CDs.
[0044] 3.3 Fourier Transform Infrared Spectroscopy Characterization (FT-IR)
[0045] FT-IR was used to characterize and analyze the chemical composition and surface functional groups of C-CDs.
[0046] 3.4 X-ray photoelectron spectroscopy (XPS) characterization
[0047] XPS was used to analyze the surface chemical composition and functional groups of C-CDs.
[0048] 3.5 Ultraviolet-Vis Spectroscopic Characterization (UV-vis)
[0049] The absorption peaks and optical properties of C-CDs were analyzed using UV-Vis.
[0050] 3.6 Steady-state fluorescence spectroscopy characterization (PL)
[0051] PL was used to analyze the optical properties of C-CDs.
[0052] 4. Data Analysis
[0053] Data processing and statistical analysis were performed using GraphPad Prism 9.5 (GraphPad Software, San Diego, CA) and Origin 21 (OriginLab Corporarion, Northampton, MA). Experimental data are presented as mean ± standard deviation (Mean ± SD). One-way ANOVA was used to compare differences between groups. P<0.05 indicates a statistically significant difference. P<0.01 indicates a statistically significant difference.
[0054] 5. Experimental Results
[0055] 5.1 Preparation method of C-CDs
[0056] In the grafting reaction, the carboxyl groups on the surface of carbon quantum dots react with the amino groups on carboxymethyl chitosan. This is the purpose of grafting, but excessive cross-linking can cause linear chitosan molecules to form a three-dimensional network structure (similar to a hydrogel), thus becoming insoluble. Therefore, when the mass ratio of CQDs to CMCS is 5:1 and 10:1, the synthesized products have similar fluorescence intensity to CQDs (…). Figure 1 A), but its water solubility is poor; when the mass ratio of CQDs to CMCS is 20:1 and 25:1, the water solubility is improved but the fluorescence intensity decreases significantly. Figure 1 B), and flocculation occurred during the addition of NHS / EDC. However, when the mass ratio of CQDs to CMCS was 15:1, its water solubility improved and no flocculation occurred during the addition of NHS / EDC, with less change in fluorescence intensity compared to CQDs. Figure 1 C). Therefore, the mass ratio of CQDs to CMCS is 15:1, and the dosage of NHS / EDC is 23mg / 9mg.
[0057] That is, the optimal preparation method is as follows: Dissolve 0.2 g CMCS in 50 mL of deionized water and stir until fully dissolved. Then, add 23 mg NHS and 9 mg EDC to the solution sequentially and continue stirring to complete the carboxyl activation reaction. Add 3 g CQDs to the reaction system and continue stirring at 200 rpm for 12 h. Filter to remove unreacted starting materials, dialyze the filtrate under the action of deionized water for 48 h, and freeze-dry at -50℃ for 72 h to obtain a brown solid.
[0058] 5.2 TEM characterization
[0059] C-CDs composites were successfully constructed via NHS / EDC-mediated amidation, and their physicochemical properties were characterized. The microstructure, lattice structure, and particle size of the C-CDs composites were characterized using TEM and a Malvern laser particle size analyzer. TEM images (…) Figure 2 (B) The images show that C-CDs are well dispersed in deionized water, with relatively uniform size and a regular spherical structure. HR-TEM images reveal that C-CDs exhibit significant lattice fringes with a lattice spacing of 0.22 nm, confirming that the synthesized C-CDs composite material still possesses a graphite-like structure. Further analysis using a Malvern laser particle size analyzer showed that the C-CDs particle size is mainly distributed in the range of 10–15 nm, with an average diameter of 13 nm. Figure 2 B), average particle size compared to individual CQDs ( Figure 2 A shows an increase in particle size (concentrated at 5nm), which indirectly verifies the successful grafting of CMCS, and the surface modification did not cause significant aggregation.
[0060] 5.3 X-ray diffraction characterization (XRD)
[0061] X-ray diffraction (XRD) patterns of CQDs, carboxymethyl chitosan (CMCS), and C-CDs were analyzed to observe their crystal structures and graphitization characteristics. Figure 3 As shown, the broad diffraction peak at 2θ = 21.12° in the XRD pattern of CQDs corresponds to an amorphous carbon structure. The introduction of CMCS shifted this broad diffraction peak (Δ2θ = 2.02°), indicating that the groups in CMCS enhanced interlayer π-π interactions, promoting the longitudinally ordered arrangement of sp² hybrid carbon domains. This is mainly because the carboxyl groups (-COOH) and amino groups (-NH) of CMCS covalently bind to sp³ defect sites (such as hydroxyl groups and dangling bonds) on the CQDs surface, reducing unsaturated defect states and thus shifting the broad diffraction peak, promoting the transformation of more disordered carbon into graphitic carbon.
[0062] 5.4 Fourier Transform Infrared Spectroscopy Characterization (FT-IR)
[0063] The surface functional groups and chemical elements of C-CDs were analyzed by FT-IR. The infrared results are as follows: Figure 4 As shown, at 3489.23 cm - ¹ and 3415.93 cm - ¹ The two peaks are bimodal (characteristic of primary amides), 1680–1630 cm⁻¹ - ¹The interval contains C=O stretching vibrations (amide I band) and 1570–1510 cm⁻¹ - The NH bending vibration (amide II band) in the ¹ region, these peaks are characteristic peaks of amide bonds formed by the amidation reaction between free -NH2- on CQDs and -COOH- on CMCS, 2800~3000 cm⁻¹ - The absorption peak in the ¹ region corresponds to the stretching vibration of saturated sp³ hybrid CH, 1000–1300 cm⁻¹. - The absorption peak in the ¹ region is characteristic of CO stretching vibrations. This indicates that CMCS was successfully grafted onto the CQDs surface.
[0064] 5.5X-ray photoelectron spectroscopy (XPS) characterization
[0065] To further confirm the successful recombination of CQDs and CMCS to form C-CDs, X-ray photoelectron spectroscopy (XPS) was used to characterize the surface elemental composition and chemical state of the samples. Full-spectrum scanning results showed ( Figure 5 C-CDs contain C, N, and O elements simultaneously, consistent with the precursor composition of CQDs and CMCS. Further peak fitting was performed on the high-resolution C1s spectrum. Figure 6Characteristic peaks belonging to C–C / C=C, CN, and C=O were observed near 284.8 eV, 286.3 eV, and 287.8 eV, respectively. Compared with pure CQDs, the C=O peak intensity in C-CDs was significantly enhanced, and a more pronounced CN peak (approximately 285.6 eV) appeared, confirming that oxygen-containing functional groups and amino groups in the CMCS molecule successfully participated in the surface modification of the carbon core. Furthermore, the O1s spectrum of C-CDs (… Figure 6 The peaks at 531.5 eV and 532.0 eV correspond to C=O and COC, respectively, while in the N1s spectrum ( Figure 6 The peak at approximately 400.0 eV was assigned to amide nitrogen. Compared to CQDs and CMCS, the CN content of C-CDs was significantly increased, a result consistent with the FTIR results. These results indicate that CQDs and CMCS form C-CDs with abundant surface functional groups through chemical bonding, rather than through simple physical mixing, thus confirming the successful synthesis of C-CDs.
[0066] 5.6 Ultraviolet-Vis (UV-vis) spectroscopy and fluorescence spectroscopy characterization (PL)
[0067] The optical properties of CQDs before and after grafting were compared using UV-Vis and PL. The UV results are as follows: Figure 7 As shown in Figure A, the UV absorption peak at 350 nm of C-CDs is reduced, which may be due to CMCS grafting onto the surface of CQDs. Next, the fluorescence intensity of CQDs and C-CDs was compared under the same conditions. Figure 7 (B) The fluorescence intensity decreased somewhat after grafting, mainly because CMCS itself is non-fluorescent, and its grafting damaged the surface passivation layer of CQDs to some extent. From the above FT-IR, XPS, UV, and PL results, it can be concluded that CMCS was successfully grafted onto the surface of CQDs.
[0068] The photoluminescence properties of C-CDs in the excitation wavelength range of 300–400 nm were then investigated, such as… Figure 8 As shown, C-CDs exhibit stable emission behavior independent of excitation energy in the excitation range of 300~400 nm. When the excitation wavelength increases from 300 nm to 360 nm, the fluorescence intensity gradually increases; however, the intensity decreases after exceeding 350 nm, but the emission peak position remains stable. This fluorescence characteristic independent of excitation wavelength mainly stems from the uniformity of the surface state of C-CDs and the monodisperse size distribution characteristics, thereby overcoming the signal interference caused by different excitation wavelengths.
[0069] 6. Summary
[0070] By optimizing the mass ratio of CQDs to CMCS and the amount of crosslinking agent, the optimal synthesis conditions were determined to be a CQDs to CMCS mass ratio of 15:1 and an NHS / EDC dosage of 23 mg / 9 mg. Under these conditions, the product exhibited good water solubility and minimal loss in fluorescence intensity. The physicochemical properties of C-CDs were systematically characterized using multiple techniques including TEM, XRD, FT-IR, XPS, UV-vis, and PL. TEM showed that the C-CDs were regularly spherical, uniformly dispersed, with an average particle size of approximately 13 nm and a lattice spacing of 0.22 nm. The characteristic diffraction peaks of CQDs in the XRD pattern shifted, confirming that CMCS grafting promoted the ordered arrangement of carbon nuclei. Both FT-IR and XPS detected characteristic signals of amide bonds, clearly confirming the successful covalent recombination of CMCS and CQDs. Optical characterization results showed that C-CDs possessed a characteristic UV absorption peak near 350 nm, and their fluorescence emission behavior was independent of the excitation wavelength. The emission peak position was stable under 360 nm excitation, exhibiting excellent optical stability. This embodiment successfully prepared a C-CDs composite material with a well-defined structure and stable performance, providing a core functional material for subsequent decontamination efficiency evaluation and real-time monitoring research.
[0071] Example 2
[0072] Research on the elution and real-time feedback of C-CDs for strontium, cesium, and thorium
[0073] Experiments were conducted using the C-CDs composite material prepared using the optimal scheme of Example 1.
[0074] 1. Experimental Methods
[0075] 1.1 Evaluation of the decontamination effect of C-CDs on strontium, cesium, and thorium
[0076] Healthy guinea pigs were selected. The day before, the pigs underwent a back hair removal pretreatment, shaving the central hair on their backs (4 cm × 4 cm area) and applying hair removal cream evenly for approximately 30 seconds. Immediately afterward, the pigs were rinsed with appropriately warm deionized water and gently dried with medical gauze. Skin integrity was observed, and any pigs with epidermal damage were removed. Pigs without epidermal damage were transferred to independent, well-ventilated cages to prevent secondary contamination of the experimental area. The following day, the pigs were anesthetized by an intraperitoneal injection of 3% sodium pentobarbital. The experimental area (2 cm × 2 cm area) was precisely marked on the shaved area using a medical marker pen. Strontium, cesium, and thorium solutions at concentrations of 1 g / L were used as treatment agents. 40 μL of each solution was evenly applied to the experimental area, ensuring complete coverage of the target surface. The total contact time was 5 minutes. Subsequently, 10 mL of the test solution was used to rinse the treated area on the back. The wash solution and peripheral blood were collected, and the back skin was excised. Five parallel samples were prepared for each group. The samples were then nitrated and stored at 4°C. Inductively coupled plasma mass spectrometry (ICP-MS) was then performed to measure the contents of strontium, cesium, and thorium according to the analytical methods established in the laboratory previously (Table 3). Skin clearance rate (%) and disinfection rate (%) were calculated using formula (1).
[0077] Disinfection rate % = (AB) / A × 100% (1); Where A represents the mean skin residue level in the blank group (ng / g); and B represents the skin residue level in each treatment group (ng / g).
[0078] Table 3 ICP-MS Instrument Parameters
[0079] 1.2 Dynamic fluorescence detection during the disinfection process
[0080] Healthy guinea pigs meeting the required weight were selected as experimental subjects. Twenty-four hours prior to the experiment, the backs of the animals were prepared by shaving the hair in the central area (4 cm × 4 cm). A chemical depilatory agent was applied and kept in contact for 30 seconds, immediately rinsed with warm deionized water, and gently dried with medical gauze. The skin integrity was observed, and any animals with epidermal damage were removed. Suitable animals were transferred to independent, well-ventilated cages to prevent secondary contamination of the experimental area. The following day, the guinea pigs were anesthetized by intraperitoneal injection of 3% sodium pentobarbital. The experimental area (2 cm × 2 cm) was precisely marked on the shaved area using a medical marker pen. Take 80 μL of each of the strontium, cesium, and thorium solutions (8 g / L) and apply them evenly to the labeled skin. After exposure, rinse with C-CDs solution (2 g C-CDs dissolved in 100 mL of pure water to prepare a 2% (w / v) solution). Take 2 mL each time and repeat 5 cycles. Collect each rinse solution independently in a centrifuge tube, dilute it in equal volumes, and observe the fluorescence under a uniform excitation and emission wavelength.
[0081] 1.3 Effects of Strontium, Cesium, and Thorium on the Fluorescence Lifetime of C-CDs
[0082] The changes in the ultraviolet absorption peaks of C-CDs before and after contact with strontium, cesium, and thorium were detected using an ultraviolet-visible spectrometer (UV-vis). The fluorescence lifetime of C-CDs before and after contact with strontium, cesium, and thorium was tested using a transient / steady-state fluorescence spectrometer, and the fluorescence lifetime was analyzed and calculated according to formula (2).
[0083] (2); In the formula, A1 and A2 represent the contents of the two fluorescent materials, and τ1 and τ2 represent the time-resolved decay lifetimes of the two fluorescent materials.
[0084] 1.4 Effects of Strontium, Cesium, and Thorium on C-CD Particle Size / Potential
[0085] The particle size and zeta potential of C-CDs composite materials before and after the interaction of strontium, cesium, and thorium ions were characterized and measured using a Malvern laser particle size analyzer. C-CDs samples were dispersed in deionized water, and then one drop of nonionic surfactant Tween80 was added. The mixture was sonicated for 1 min to ensure complete dispersion of the solutes. Immediately after sonication, the samples were transferred to quartz cuvettes and placed in the groove. The samples were grouped as follows: (1) blank control group (pure C-CDs); (2) blank control group (pure CMCS); (3) low concentration Sr 2+ Group (2.5 mg / L); (4) High concentration Sr 2+ Group (5 mg / L); (5) Low concentration Sr 2+ Group (2.5 mg / L); (6) High concentration Sr 2+ Group (5 mg / L); (7) Low concentration Sr 2+ Group (2.5 mg / L); (8) High concentration Sr 2+ Group (5 mg / L).
[0086] Response time of 1.5C-CDs to strontium, cesium, and thorium
[0087] Each time, 200 μL of C-CDs solution (2 g C-CDs dissolved in 100 mL of pure water to prepare a 2% (w / v) solution) was taken into a centrifuge tube, and strontium, cesium, and thorium ion solutions were added. The reaction system was immediately detected using a fluorescence spectrometer. The instrument parameters were set as follows: excitation wavelength 360 nm, emission wavelength 445 nm.
[0088] 1.6 Quenching efficiency of Strontium, Cesium, and Thorium on C-CD fluorescence
[0089] To investigate the quenching behavior of typical metal ions (strontium, cesium, and thorium) on the fluorescence of carbon quantum dot-carboxymethyl chitosan (C-CDs) composites, a systematic fluorescence spectrophotometric method was used. 200 μL of strontium, cesium, and thorium metal ion solutions were added to the C-CDs composite solution, and the reaction was carried out at room temperature in the dark for a certain period. The fluorescence intensity of each system was measured at the optimal excitation and emission wavelengths using a fluorescence spectrophotometer, and the quenching efficiency (QE) was calculated. (3); Wherein, F0 and F are the fluorescence intensities before and after the addition of metal ions, respectively.
[0090] 1.7 Data Analysis
[0091] Data processing and statistical analysis were performed using GraphPad Prism 9.5 (GraphPad Software, San Diego, CA) and Origin 21 (OriginLab Corporarion, Northampton, MA). Experimental data are presented as mean ± standard deviation (Mean ± SD). One-way ANOVA was used to compare differences between groups. P<0.05 indicates a statistically significant difference. P<0.01 indicates a statistically significant difference.
[0092] 2. Experimental Results
[0093] 2.1 Decontamination capability test
[0094] In the evaluation of the effectiveness of radioactive contamination decontamination agents, the ability to remove radionuclides is the primary evaluation indicator. Based on the requirements of the "Standard for Treatment of Radionuclide Contamination on Human Body Surface" (GBZ / T 216-2024), a guinea pig skin model was used to simulate the battlefield Sr 2+ Cs + ,Th 4+ In contaminated scenarios, the effects of four different disinfectants on Sr were systematically evaluated. 2+ Cs + ,Th 4+ The disinfection efficacy was assessed. An experiment was conducted with a 5-minute exposure time, using normal saline (NS) as a control. The disinfection effects of NS, CQDs solution, CMCS solution, and C-CDs composite solution were simultaneously tested, and the disinfection rate (%) was calculated using the formula. Figure 9 A, Figure 10 A, Figure 11 A is the Sr group of each group 2+ Cs + ,Th 4+The disinfection rates were as follows: NS group: 69.91%; CQDs group: 84.59%; CMCS group: 87.74%; C-CDs group: 95.98%. Based on these results, the C-CDs and CMCS groups showed the best disinfection performance against Sr. 2+ Cs + ,Th 4+ The detergency of the C-CDs group was significantly higher than that of the NS and CQDs groups, and the C-CDs group solution was also significantly better at removing Sr. 2+ Cs + ,Th 4+ The decontamination rates were all higher than those of the CMCS group. ICP-MS was used to detect the strontium, cesium, and thorium content in the decontamination solution, and the results are as follows: Figure 9 B Figure 10 B Figure 11 As shown in B, Sr in group NS 2+ Cs + ,Th 4+ The concentration of Sr in the CQDs group was 0.0097 mg; the concentration of Sr, cesium, and thorium in the CQDs group was 0.016 mg, which was 1.62 times that of the NS group; the concentration of Sr, cesium, and thorium in the CMCS group was 0.017 mg, which was 1.75 times that of the NS group; the concentration of Sr, cesium, and thorium in the C-CDs group was 0.018 mg, which was 1.86 times that of the NS group. 2+ Cs + ,Th 4+ The enrichment level was positively correlated with skin decontamination rate, confirming that C-CDs have a stronger retention capacity for strontium, cesium, and thorium nuclides. Regarding biosafety assessment, guinea pig whole blood Sr... 2+ Cs + ,Th 4+ The concentrations were all below the detection limit, indicating that intact skin has a significant barrier effect against uranium nuclide penetration. These results fully demonstrate that C-CDs exhibit a significant advantage over CMCS in strontium, cesium, and thorium removal efficiency, and can more effectively compete with skin surface tissue for uranium, thereby improving decontamination efficiency.
[0095] 2.2 Real-time monitoring capability test
[0096] To address the limitations of traditional handheld radionuclide detectors during decontamination at nuclear accident sites, a dynamic monitoring system based on C-CDs composite materials was constructed. The fluorescence response characteristics of this material during the decontamination process of strontium, cesium, and thorium contamination were experimentally evaluated, along with the feasibility of quantitative monitoring. To accurately assess the decontamination process, a staged decontamination strategy was employed, dividing a 10 mL C-CDs solution into five equal portions for sequential rinsing, collecting the decontamination solution at each stage for analysis. Figure 12 , Figure 13 , Figure 14 As shown, the fluorescence intensity and Sr in the decontamination solution at each stage were compared using fluorescence spectroscopy and ICP-MS. 2+ Cs+ ,Th 4+ The content was quantitatively analyzed in triplicate. Fluorescence results are shown below. Figure 12 A, Figure 13 A, Figure 14 As shown in Figure A, the fluorescence intensity of C-CDs in the first-stage decontamination solution decreased by 68.2%, 67.2%, and 79.8% compared to the blank group, respectively. With the reduction of Sr... 2+ Cs + ,Th 4+ With increasing elution cycles, the fluorescence intensity showed a gradient recovery trend. The fluorescence intensity collected on the fifth elution cycle recovered to 96.6%, 95.8%, and 97.9% of the original value, respectively, demonstrating that for Sr on the skin surface... 2+ Cs + ,Th 4+ The disinfection process is basically complete. The ICP-MS quantitative results are as follows: Figure 12 B Figure 13 B Figure 14 As shown in B, Sr in the first stage C-CDs decontamination solution 2+ Cs + ,Th 4+ The content of Sr was higher than that of the CMCS group and CQDs, indicating that the synergistic effect of the composite material significantly optimized the Sr content. 2+ Cs + ,Th 4+ The binding ability of C-CDs proves that Sr is more efficient. 2+ Cs + ,Th 4+ Removal performance. This experiment confirmed the feasibility of monitoring the decontamination process through real-time fluorescence signals. Fluorescence recovery occurred simultaneously with the removal of strontium, cesium, and thorium, overcoming the limitations of traditional detection equipment in terms of real-time performance, sensitivity, and operational safety, and providing a new dynamic monitoring solution for nuclear emergency decontamination operations.
[0097] 2.3 Fluorescence lifetime
[0098] Sr was examined 2+ Cs + ,Th 4+ Whether C-CDs can be quenched by fluorescence was first determined using transient / steady-state fluorescence spectroscopy to compare the fluorescence of C-CDs with that of Sr. 2+ Cs + ,Th 4+ Fluorescence lifetime was tested before and after contact, such as... Figure 15 As shown, Sr 2+ Cs + ,Th 4+All of these factors reduced the fluorescence lifetime of C-CDs by 1.03 ns, 0.9 ns, and 2.58 ns, respectively. This reduction in fluorescence lifetime is a typical characteristic of dynamic quenching (collision quenching). During dynamic quenching, excited-state C-CDs collide or interact with metal ions, providing additional non-radiative decay pathways for excited-state electrons, increasing the overall decay rate constant, and thus reducing the fluorescence lifetime. Th... 4+ The most significant reduction in lifespan is caused by Th. 4+ The higher charge density and stronger coordination ability are related to its ability to quench the fluorescence of C-CDs.
[0099] 2.4C-CDs and Sr 2+ Cs + ,Th 4+ Interactive fluorescence quenching mechanism
[0100] To clarify C-CDs and Sr 2+ Cs + ,Th 4+ The fluorescence quenching mechanism of the interaction was systematically analyzed experimentally using a combination of UV-Vis absorption spectroscopy and Malvern particle size analyzer for multi-dimensional characterization. The UV-Vis absorption spectroscopy (UV-Vis absorption spectroscopy) Figure 16 It was found that C-CDs solution, upon the addition of Sr 2+ Cs + ,Th 4+ Subsequently, the intensity of its characteristic absorption peak did not show significant shift or deformation, further ruling out a static quenching mechanism. Furthermore, the Zeta potential results showed ( Figure 17 The surface potential of C-CDs solution is -31.68 mV, while that of Sr is... 2+ Cs + ,Th 4+ After interaction, their Zeta potentials became -8 mV, -21.06 mV, and 20.72 mV, respectively. The decrease in the magnitude of the surface negative charge indicates that C-CDs interact with Sr. 2+ Cs + ,Th 4+ There is a strong electrostatic interaction between them, and the weakening of the electrostatic repulsion is a key factor in inducing the aggregation of C-CDs, indicating that C-CDs and Sr... 2+ Cs + ,Th 4+ Aggregation quenching effects may occur between particles, therefore their particle size distribution is detected. For example... Figures 18-20 As shown, the original C-CDs exhibited a monodisperse particle size distribution (5~17 nm), while the particle size of Sr-added C-CDs decreased. 2+ Cs + ,Th 4+Subsequently, aggregates with a size >150 nm were formed, and the degree of aggregation was similar to that of Sr. 2+ Cs + ,Th 4+ Concentration is positively correlated. This phenomenon is consistent with the aggregation-induced quenching (ACQ) mechanism, where the aggregation of nanomaterials leads to enhanced π-π stacking and activation of non-radiative transition channels. Notably, the aggregate size significantly exceeds the average diameter of stratum corneum pores (10–40 nm), suggesting that this composite material has a size-limiting effect in skin penetration applications, effectively reducing potential bio-penetration risks.
[0101] 2.5 Quenching efficiency of Strontium, Cesium, and Thorium on C-CD fluorescence
[0102] Based on the abundant functional groups on the surface of C-CDs and Sr 2+ Cs + ,Th 4+ Coordination mechanism, evaluating the effect of C-CDs on Sr 2+ Cs + ,Th 4+ The chelating ability of CMCS was improved by comparing the fluorescence quenching behavior of the original CQDs and C-CDs. It was found that the modification of CMCS significantly improved the material's chelating ability of Sr. 2+ Cs + ,Th 4+ The response sensitivity. For example... Figure 21 As shown in Table 4, under the same experimental conditions, the fluorescence quenching rates (QF) of C-CDs under the influence of the three nuclides were 0.92, 0.91, and 0.97, respectively, all of which were higher than the QF values of unmodified CQDs (0.84, 0.81, and 0.93). This demonstrates that CMCS modification promotes the interaction between C-CDs and Sr. 2+ Cs + ,Th 4+ The combination of these factors leads to an enhanced quenching effect.
[0103] Table 4 CQDs, C-CDs and Sr 2+ Cs + ,Th 4+ Fluorescence quenching rate after contact
[0104] 2.6C-CDs response time to strontium, cesium, and thorium
[0105] The study of response time is particularly important for radionuclides because rapid detection of the nuclide is necessary in the event of a leak. To verify the relationship between C-CDs and Sr... 2+ Cs + ,Th 4+ Whether an immediate quenching effect occurs upon contact is therefore important for the study of C-CDs and Sr.2+ Cs + ,Th 4+ The response time after contact was studied. For example... Figures 22-24 As shown, Sr is added to C-CDs 2+ Cs + ,Th 4 + Subsequently, the fluorescence intensity of C-CDs underwent fluorescence quenching at 10 s, and the fluorescence signals at subsequent time points (0–60 min) were detected; the fluorescence signal of C-CDs remained stable after quenching. In summary, C-CDs inhibit the fluorescence intensity of Sr... 2+ Cs + ,Th 4+ The response is rapid, and the fluorescence signal intensity remains stable after quenching. This indicates that C-CDs can achieve rapid detection of Sr. 2+ Cs + ,Th 4+ This is of great significance for scenarios that require rapid response in practical applications (such as emergency monitoring).
[0106] 3. Summary
[0107] Guinea pig skin model experiments showed that C-CDs achieved a decontamination rate of 95.98% for strontium, cesium, and thorium, significantly higher than the saline group (69.91%), CQDs group (84.59%), and CMCS group (87.74%). ICP-MS analysis of the nuclide content in the decontamination solution yielded consistent results, confirming that CMCS grafting significantly enhanced the material's complexation and retention capacity for nuclides. Real-time monitoring experiments using a graded decontamination strategy revealed that the fluorescence intensity of C-CDs recovered gradually with increasing rinsing cycles, reaching over 96% of its initial value after the fifth decontamination. This recovery closely matched the decreasing trend of nuclide content measured by ICP-MS, achieving for the first time dynamic feedback of fluorescence signal on the degree of nuclide removal during the decontamination process. Mechanistic studies indicated that Sr² + Cs + ,Th 4+ All of them can cause fluorescence quenching of C-CDs, among which Th 4+The effect is most potent. Fluorescence lifetime tests showed that the lifetime was shortened after the addition of metal ions (reduced by 1.03, 0.9, and 2.58 ns, respectively). Combined with evidence such as no significant change in the UV absorption peak, a change from negative to positive zeta potential, and a significant increase in particle size (>150 nm), this confirms that the quenching mechanism is a synergistic effect of dynamic quenching and aggregation-induced quenching. Response time experiments showed that fluorescence quenching occurred within 10 seconds after C-CDs came into contact with the nuclide, with a rapid response and stable signal. In summary, C-CDs not only possess efficient and broad-spectrum decontamination capabilities but also overcome the limitations of traditional detection equipment, enabling real-time fluorescence visualization monitoring of the decontamination process, providing a novel intelligent solution for nuclear emergency response.
[0108] Example 3
[0109] C-CDs security research
[0110] Experiments were conducted using the C-CDs composite material prepared using the optimal scheme of Example 1.
[0111] This embodiment uses New Zealand white rabbits and SPF-grade male mice for experiments.
[0112] 1. Experimental Methods
[0113] 1.1 In vitro cytotoxicity assay
[0114] Mouse fibroblasts (L929) were used, and the cytocompatibility of C-CDs was detected using the MTT assay. Groups were set up as a blank control group and groups with different concentrations of C-CDs (100 μg / mL, 50 μg / mL, 25 μg / mL, 12.5 μg / mL, 6.25 μg / mL, and 3.1 μg / mL). The cells were co-cultured with L929 cells in a constant temperature incubator for 24 h, 48 h, and 72 h, with three biological replicates for each treatment group. The optical density values of each well were read using a full-wavelength microplate reader in dual-wavelength mode (main measurement wavelength 570 nm, background correction wavelength 650 nm). Cell viability was calculated by the ratio of absorbance of the experimental group to that of the control group. Cell viability (%) = A / B × 100% (4); In the formula, A and B are the average absorbance values of the C-CDs sample group and the blank control group, respectively.
[0115] 1.2 Skin irritation test
[0116] GB / T 21604-2022, "Test Methods for Acute Skin Irritation / Corrosion of Chemicals," is a core technical specification for evaluating the skin contact safety of chemicals. Using a New Zealand rabbit animal model, the acute skin irritation / corrosion potential of C-CDs composite materials was assessed, providing a basis for the safety evaluation of chemical raw materials.
[0117] (1) Sample preparation: Negative control group: 0.5 mL physiological saline solution; Sample group: 0.5 mL C-CDs solution (2 g C-CDs dissolved in 100 mL pure water to prepare a 2% (w / v) solution); Positive control group: 0.5 mL 20% sodium dodecyl sulfate solution (SDS). Carrier: A sterilized four-layer cotton dressing (square with a side length of 2.5 cm) was used as the drug loading matrix, which was applied after being soaked in the test substance.
[0118] (2) Method: Three healthy adult New Zealand rabbits were selected. 24 hours before the experiment, their backs underwent hair removal pretreatment. Three intact, undamaged 3 cm × 3 cm experimental areas were selected on each side of the back, spaced ≥ 2 cm apart, and labeled as the sample group, negative control, and positive control. The soaked gauze was then applied to (…). Figure 25 Apply the dressing to the target area as shown, then secure it with hypoallergenic breathable tape or elastic bandage for 24 hours. Immediately after application, rinse the treated area with warm water and pat dry. Perform a systematic skin assessment at 1, 24, 48, and 72 hours post-treatment, taking photographs and recording indicators such as erythema formation, edema, and epidermal desquamation.
[0119] (3) Result determination: According to the standard, the total score of erythema and edema of the test animals is summarized at the preset observation time points according to Table 5. Then, the total score at each time point is divided by the sample size of the experimental animals to obtain the average stimulus score (PII) for that period. The calculated PII needs to be classified according to the grading standard table (Table 6).
[0120] Table 5 Skin Reaction Scoring System (Adapted from GB / T 16886.10 standard)
[0121] Table 6 Skin Reaction Scoring Table (Adapted from GB / T 16886.10 standard)
[0122] 1.3 Acute toxicity test
[0123] In accordance with the requirements of the national standard GB / T16886.11-2011 "Biological Evaluation of Medical Devices Part 11: Systemic Toxicity Testing", the systemic acute toxicity of C-CDs administered intraperitoneally to mice was evaluated. Male Kunming mice were selected and randomly divided into three groups based on body weight: a negative control group (saline), a sample group (CQDs), and a sample group (C-CDs), with 10 mice in each group. The mice were marked with picric acid. The experimental animals were administered a single intraperitoneal injection of 50 mg / kg of either the sample or saline. Immediate systemic acute toxicity (0–4 h) and long-term toxicity (1–14 days) were continuously monitored after administration. The weight of the experimental animals was measured daily, and necropsy was performed on animals in the suspected lesion group.
[0124] 1.4 Data Analysis
[0125] Data processing and statistical analysis were performed using GraphPad Prism 9.5 (GraphPad Software, San Diego, CA) and Origin 21 (OriginLab Corporarion, Northampton, MA). Experimental data are presented as mean ± standard deviation (Mean ± SD). One-way ANOVA was used to compare differences between groups. P<0.05 indicates a statistically significant difference. P<0.01 indicates a statistically significant difference.
[0126] 2. Experimental Results
[0127] 2.1 In vitro cytotoxicity assay
[0128] The cytotoxicity of C-CDs was systematically evaluated using the MTT assay. The experimental results are as follows: Figure 26 As shown, cell viability was ≥80% at all time points (cell viability ≥80% is considered cytotoxic), demonstrating that C-CDs have low cytotoxicity to L929 cells and good cell compatibility, meeting the national standard (GB / T16886.5-2017). Furthermore, it is noteworthy that the normal growth and cell viability of L929 cells treated with C-CDs were significantly enhanced within 72 h.
[0129] 2.2 Skin irritation test
[0130] The skin irritation experiment reflected the irritation of C-CDs on the skin of New Zealand rabbits, and observed its potential skin irritation response. Based on the experimental data (Table 7) and the New Zealand rabbit skin response map (…),… Figure 27As observed, the positive control group (SDS) exhibited significant inflammatory response characteristics in the tested area, including visible erythema and edema, meeting the criteria for severe irritation (PII ≥ 2.0). In contrast to the significant response in the positive control group, no erythema or edema was detected in the C-CDs group at any time point (PII = 0.0 ± 0.0), showing no statistically significant difference compared to the negative control group (PII = 0.0 ± 0.0). This experiment, using an animal model, validated that C-CDs did not induce skin irritation upon contact with New Zealand rabbit skin, meeting national biological evaluation standards and providing a safety basis for subsequent clinical applications.
[0131] Table 7 Skin reactions of each treatment group at 1, 24, 48, and 72 h in the New Zealand rabbit skin irritation experiment (n=3)
[0132] 2.3 Acute toxicity test
[0133] To ensure the safety of clinical drug use, compounds intended for human use must undergo acute toxicity assessment. This study used Kunming mice to assess the systemic acute toxicity of C-CDs. After a single intraperitoneal injection of normal saline (NS) and C-CDs samples at a dose of 50 mg / kg, the mice were continuously observed for 15 days. The weight changes of Kunming mice over 15 days are shown below. Figure 28 As shown, survival analysis indicated that the 15-day survival rate was 100% in all groups, with steady weight gain. No signs of neurotoxicity such as convulsions or ataxia were observed, and hair luster was not different from the control group. This experimental assessment confirmed that the C-CDs group had good biocompatibility and no acute toxic reactions occurred.
[0134] 3. Summary
[0135] In vitro cytotoxicity experiments were conducted using the MTT assay to detect the effect of C-CDs on the proliferation of mouse fibroblasts (L929). Results showed that within the concentration range of 3.1–100 μg / mL, L929 cells maintained ≥80% viability after 24, 48, and 72 hours of culture, meeting the national standard for non-cytotoxicity. Furthermore, cell growth remained good within 72 hours, with no inhibitory effect observed. Skin irritation experiments were performed according to GB / T 21604-2022. C-CDs were applied to the back skin of New Zealand rabbits, and skin reactions were observed at 1, 24, 48, and 72 hours after 24 hours of closed contact. Results showed that the C-CDs group did not exhibit erythema, edema, or other irritation symptoms at any time point, with a primary irritation index (PII) of 0, which was not different from the saline negative control group, indicating a very mild irritation reaction. In contrast, the positive control SDS group showed severe irritation (PII=5). Acute toxicity experiments involved a single intraperitoneal injection of 50 mg / kg C-CDs solution into Kunming mice, with continuous observation for 15 days. The results showed that the survival rate of mice in the C-CDs group was 100%, and their body weight showed a steady increasing trend, with no significant difference compared to the saline group and the CQDs group. No neurotoxic signs, behavioral abnormalities, or deaths were observed. In conclusion, C-CDs exhibit excellent biocompatibility and low toxicity at the in vitro cellular level, skin contact level, and systemic exposure level, meeting the mandatory requirements for biological evaluation of medical devices and providing sufficient safety data support for their subsequent clinical translation and nuclear emergency field application.
[0136] As demonstrated in the above examples, C-CDs composite materials are obtained by covalently modifying the surface of CQDs with carboxymethyl chitosan (CMCS) via an amidation reaction. This solves the core problems of traditional decontamination agents, such as limited functionality and delayed monitoring, and provides a novel intelligent solution for nuclear emergency surface contamination treatment.
[0137] The above description is only a preferred embodiment of the present invention. It should be noted that for those skilled in the art, several improvements and modifications can be made without departing from the principle of the present invention, and these improvements and modifications should also be considered within the scope of protection of the present invention.
Claims
1. A carbon quantum dot composite material, characterized in that, It includes the following components: Carboxymethyl chitosan, carbon quantum dots (CQDs), and crosslinking agents; The mass ratio of carbon quantum dots (CQDs) to carboxymethyl chitosan is 5-25:
1. The crosslinking agent is N-hydroxysuccinimide and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide; The mass ratio of N-hydroxysuccinimide to 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide is 1~3:1; The mass ratio of carboxymethyl chitosan to crosslinking agent is 0.5~7:
1.
2. A method for preparing a carbon quantum dot composite material, characterized in that, Includes the following steps: (1) Mix carboxymethyl chitosan, carbon quantum dots (CQDs) and crosslinking agent with water and stir for 10-14 hours to obtain a mixture; (2) Filter the mixture, take the filtrate, dialyze for 45-51 hours, and dry to obtain carbon quantum dot composite material.
3. The preparation method according to claim 2, characterized in that, The stirring speed is 150~250 rpm.
4. The preparation method according to claim 2, characterized in that, The drying process is freeze drying; the freeze drying temperature is -45℃ to -55℃; and the freeze drying time is 70 to 74 hours.
5. The application of the carbon quantum dot composite material according to claim 1 or the carbon quantum dot composite material prepared according to any one of claims 2 to 4 in radionuclide decontamination and monitoring of decontamination effect.
6. The application according to claim 5, characterized in that, The nuclide is one or more of strontium, cesium, and thorium.
7. The application according to claim 5, characterized in that, The scenarios for radionuclide decontamination using the carbon quantum dot composite material include decontamination of radionuclide-contaminated wounds, decontamination of radionuclide-contaminated human skin surfaces, or decontamination of radionuclide-contaminated object surfaces.
8. The application of the carbon quantum dot composite material according to claim 1 or the carbon quantum dot composite material prepared according to any one of claims 2 to 4 in the preparation of products that can simultaneously perform radionuclide decontamination and monitor the decontamination effect in real time.
